Article
Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
Hepatology (Baltimore, Md.) - 1 Aug 2007
Steinmann Eike, Whitfield Thomas, Kallis Stephanie, Dwek Raymond A, Zitzmann Nicole, Pietschmann Thomas, Bartenschlager Ralf
Abstract excerpt
UNLABELLED: Current therapy of chronic hepatitis C is based on the combination of pegylated interferon-alpha and ribavirin. In spite of 50% sustained virological response, therapy is still limited by unsatisfying success rates with genotype 1 infections and adverse side effects. One attempt to in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
